Erin Clark serves as Sesen Bio’s vice president of corporate strategy and investor relations. Ms. Clark brings significant experience in the strategy and commercialization of late-stage life science companies. Prior to joining us, Ms. Clark held various leadership roles at Trevena, Inc. and Orexigen Therapeutics, Inc., where she helped drive commercialization and realization of external value drivers for lead assets in development and approved marketed products. Prior to her roles at Trevena and Orexigen, Ms. Clark worked as a consultant at Deloitte where she led quantitative and qualitative market assessments for small and large life science clients. Ms. Clark began her career at Johnson and Johnson where she played key roles in supporting multi-billion-dollar products across the pharmaceutical portfolio. Ms. Clark received her Bachelor of Science in Finance from Pennsylvania State University.